Carole Bourquin
Carole Bourquin is a prominent professor of pharmacology at the University of Bern, known for her research in the field of cancer immunotherapy. Her work focuses on the development of personalized mRNA vaccines tailored to target specific tumor proteins, aiming to enhance the effectiveness of cancer treatments. Bourquin's innovative approach utilizes large databases and AI models to identify which tumor proteins elicit strong immune responses, ultimately striving to improve patient outcomes in cancer therapy.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 1 | 8.00 | 0.09% | +0% | 8,654,622 | 7,839 | $700,000 | 634$ |
| Totals | 1 | 8,654,622 | 7,839 | $700,000 | 634$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Carole Bourquin, a professor of pharmacology at the University of Bern, emphasized the importance of characterizing cancer proteins for personalized mRNA vaccines.
8